PULMATRIX, INC. Increase (Decrease) in Deferred Charges
PULMATRIX, INC. (PULM) reported Increase (Decrease) in Deferred Charges of $17.00 thousand for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2019-11-01
- PULMATRIX, INC. increase (decrease) in deferred charges for the quarter ending 2019-09-30 was $6.00K.
- PULMATRIX, INC. increase (decrease) in deferred charges for the quarter ending 2019-06-30 was $5.00K.
- PULMATRIX, INC. increase (decrease) in deferred charges for the quarter ending 2019-03-31 was $6.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month |
|---|---|---|---|
| 2019-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $11.00K derived: sum of 2 quarters · filed 2019-11-01 | $17.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $11.00K 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $6.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |